Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$68K Sell
7,102
-8,722
-55% -$78.2K ﹤0.01% 1017
2026
Q1
$125K Sell
15,824
-27,892
-64% -$253K ﹤0.01% 928
2025
Q4
$294K Buy
43,716
+18,463
+73% +$139K ﹤0.01% 842
2025
Q3
$211K Buy
25,253
+11,589
+85% +$90.2K ﹤0.01% 854
2025
Q2
$86.1K Buy
13,664
+12,615
+1,203% +$83.5K ﹤0.01% 883
2025
Q1
$6.72K Hold
1,049
﹤0.01% 951
2024
Q4
$8.43K Sell
1,049
-1,587
-60% -$15.3K ﹤0.01% 904
2024
Q3
$33.3K Hold
2,636
﹤0.01% 942
2024
Q2
$32.4K Buy
+2,636
New +$26.5K ﹤0.01% 978
2024
Q1
Sell
-1,000
Closed -$4.91K 1084
2023
Q4
$4.91K Buy
+1,000
New +$6.12K ﹤0.01% 982
2023
Q1
Sell
-241
Closed -$1.62K 1104
2022
Q4
$1.62K Buy
+241
New +$4.25K ﹤0.01% 1026
2022
Q3
Sell
-64
Closed -$3.31K 1059
2022
Q2
$3.31K Buy
+64
New +$3.31K ﹤0.01% 1006
2022
Q1
Sell
-150
Closed -$23.2K 1093
2021
Q4
$23.2K Buy
+150
New +$25.8K ﹤0.01% 1047

Other funds holding NVAX

DZ Bank's NVAX Position: Q2 2026 in Review

DZ Bank reduced its Novavax (NVAX) stake by 55% in Q2 2026, selling an estimated $78.2K and leaving 7,102 shares worth $68K. The position accounts for ﹤0.01% of the portfolio, ranked #1017.

DZ Bank first reported a position in NVAX in Q4 2021 and has held it in 13 quarters since. The position peaked at $294K in Q4 2025. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • DZ Bank held 7,102 shares of Novavax worth $68K as of Q2 2026.
  • DZ Bank sold 8,722 Novavax shares in Q2 2026, an estimated $78.2K.
  • Novavax made up ﹤0.01% of DZ Bank's portfolio in Q2 2026, its #1017 holding.
  • DZ Bank first reported a position in Novavax in Q4 2021 and has held it in 13 quarters since.
  • DZ Bank's Novavax position peaked at $294K in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.